cancer. Brain, unspecified
Conditions
Interventions
Intervention 1: All patients in intervention group will be treated with a basic analgesia with acetaminophen (30 mg/kg/day) and fentanyl (1µg/kg/hour) by patient-controlled intravenous analgesia (PCIA
Treatment - Drugs
All patients in intervention group will be treated with a basic analgesia with acetaminophen (30 mg/kg/day) and fentanyl (1µg/kg/hour) by patient-controlled intravenous analgesia (PCIA) throughout the
All patients in control group will be treated with a basic analgesia with acetaminophen (30 mg/kg/day) and fentanyl (1µg/kg/hour) by patient-controlled intravenous analgesia (PCIA) throughout the stu
Sponsors
Mahak Hospital and Rehabilitation Complex
Eligibility
Sex/Gender
All
Age
12 Years to 22 Years
Inclusion criteria
Inclusion criteria: criteria: presence of chronic neuropathic pain; failure to provide adequate pain relief with conventional treatments. Exclusion criteria: Caudaequina syndrome; Anticoagulation, coagulopathy and suspected local or systemic infection.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. Timepoint: On days 1, 2, 3, 5, 7, 10 and 14 after injections, patient responses to treatments were evaluated. Method of measurement: questionnaire.;Adverse effect. Timepoint: On days 1, 2, 3, 5, 7, 10 and 14 after injections, patient responses to treatments were evaluated. Method of measurement: questionnaire. | — |
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: On days 1, 2, 3, 5, 7, 10 and 14 after injections, patient responses to treatments were evaluated. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Faranoush
Mahak
Outcome results
None listed